NASDAQ:RELV Reliv' International (RELV) Stock Price, News & Analysis → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free RELV Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$4.06▼$4.0650-Day Range$2.50▼$3.7352-Week Range$2.50▼$4.42VolumeN/AAverage Volume23,200 shsMarket Capitalization$7.09 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsSocial MediaStock AnalysisCompetitorsSocial Media Get Reliv' International alerts: Email Address Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About Reliv' International Stock (NASDAQ:RELV)Reliv' International, Inc. develops and markets nutritional supplements that address basic nutrition, specific wellness needs, weight management, and sports nutrition. The company's basic nutritional supplements are formulated to provide a balanced and complete level of supplementation for the consumer. Its principal products include Reliv Classic, Reliv Now, Innergize!, and FibRestore along with LunaRich X capsules. The company markets and sells its products through a direct selling system of independent distributors in the United States, Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, and the United Kingdom. Reliv' International, Inc. was founded in 1988 and is headquartered in Chesterfield, Missouri.Read More Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here RELV Stock News HeadlinesApril 18, 2024 | finance.yahoo.comAgape ATP Corporation (ATPC)March 29, 2024 | morningstar.comNorth American Morning Briefing: Stocks Set for -2-May 6, 2024 | Stansberry Research (Ad)Gold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).October 10, 2023 | finance.yahoo.comReliv Celebrates 35 Years of Nourishing the World and Introduces New Healthy Aging SystemsSeptember 16, 2022 | reuters.comReliance Naval and Engineering LtdJanuary 21, 2022 | nasdaq.comRELV Real-Time QuotesSee More Headlines Receive RELV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Reliv' International and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/15/2020Today5/05/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:RELV CUSIPN/A CIK768710 Webwww.reliv.com Phone636-537-9715FaxN/AEmployees91Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-440,000.00 Net Margins-0.61% Pretax MarginN/A Return on Equity-1.89% Return on Assets-1.31% Debt Debt-to-Equity Ratio0.05 Current Ratio1.70 Quick Ratio1.04 Sales & Book Value Annual Sales$35.06 million Price / Sales0.20 Cash Flow$0.09 per share Price / Cash Flow44.53 Book Value$6.36 per share Price / Book0.64Miscellaneous Outstanding Shares1,746,000Free FloatN/AMarket Cap$7.09 million OptionableNot Optionable Beta-0.10 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Robert L. Montgomery (Age 79)Co-Founder & Chairman Comp: $538.27kMr. Ryan A. Montgomery (Age 47)CEO & Director Comp: $218.89kMr. Thomas W. Pinnock III (Age 70)Pres of Sales & Marketing Comp: $342.38kMr. Steven D. Albright CPA (Age 59)CPA, Sr. VP & CFO Ms. Debra P. Bernardoni (Age 50)Sr. VP & COO Mr. Stephen M. Merrick (Age 79)Gen. Counsel & Sec. Mr. Donald E. Gibbons Jr. (Age 66)Sr. VP of US Sales Mr. R. Scott Montgomery (Age 51)Pres of Operations & International Mr. Kurt C. Wulff (Age 56)Sr. VP of Marketing Ms. Susan R. StoneManaging Director of Reliv Asia PacificMore ExecutivesKey CompetitorsDAVIDsTEANASDAQ:DTEA22nd Century GroupNASDAQ:XXIIReed'sNYSE:REEDSteakholder FoodsNASDAQ:STKHFarmmiNASDAQ:FAMIView All Competitors RELV Stock Analysis - Frequently Asked Questions How were Reliv' International's earnings last quarter? Reliv' International, Inc. (NASDAQ:RELV) posted its earnings results on Friday, May, 15th. The company reported $0.38 EPS for the quarter. The business earned $10.28 million during the quarter. Reliv' International had a negative net margin of 0.61% and a negative trailing twelve-month return on equity of 1.89%. What is Ryan Montgomery's approval rating as Reliv' International's CEO? 1 employees have rated Reliv' International Chief Executive Officer Ryan Montgomery on Glassdoor.com. Ryan Montgomery has an approval rating of 100% among the company's employees. This puts Ryan Montgomery in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Reliv' International own? Based on aggregate information from My MarketBeat watchlists, some companies that other Reliv' International investors own include VIVUS (VVUS), Aquestive Therapeutics (AQST), Putnam Premier Income Trust (PPT), Rite Aid (RAD), RadNet (RDNT), Rexahn Pharmaceuticals (REXN), Rigel Pharmaceuticals (RIGL), RTI Surgical (RTIX), Sonoma Pharmaceuticals (SNOA) and Sunesis Pharmaceuticals (SNSS). This page (NASDAQ:RELV) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldDollar CancelledLear CapitalRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupGold Set to EXPLODE!Gold Safe ExchangeThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reliv' International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
